FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
SPOTLIGHT: "Catching Up with Califf"
FDA’s Dietary Supplements Program Remains a Critical Priority
ODSP will remain a distinct office executing the agency’s responsibilities under the Federal Food, Drug, and Cosmetic Act for dietary supplement products.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA’s IT Strategy: Unlocking Potential, Leading Transformation
FDA has released the FDA Information Technology Strategy for Fiscal Years 2024 to 2027 marking a defining roadmap for the agency's technological advancement.
Optimizing Postapproval Safety Studies to Expand Data Generation on Medication Use in Pregnancy
Postapproval pregnancy safety studies can help guide clinical practice and provide useful information for product labeling.
Some table information
| Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
|---|